Voyageur Pharmaceuticals Ltd (VM.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
(Values in thousands)
| 11-2024 | 11-2023 | 11-2022 | 11-2021 | 11-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 2 | 2 | 9 | 2 | 1 |
| Accounts receivable | -16 | -12 | 18 | -29 | 53 |
| Accounts payable and accrued liabilities | N/A | N/A | -192 | -82 | 166 |
| Other Working Capital | 927 | 110 | -244 | -343 | 438 |
| Other Operating Activity | -1,215 | -1,092 | -1,309 | -1,203 | -930 |
| Operating Cash Flow | $-302 | $-991 | $-1,719 | $-1,654 | $-272 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | 0 | 9 | N/A | 0 |
| Other Investing Activity | -166 | -175 | -283 | -432 | -152 |
| Investing Cash Flow | $-166 | $-175 | $-274 | $-432 | $-152 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 227 |
| Debt Repayment | N/A | 0 | -17 | -19 | -4 |
| Common Stock Issued | 656 | 1,200 | 1,157 | 2,305 | 155 |
| Other Financing Activity | -24 | -63 | 71 | 610 | -27 |
| Financing Cash Flow | $632 | $1,136 | $1,211 | $2,896 | $351 |
| Beginning Cash Position | 2 | 32 | 813 | 3 | 76 |
| End Cash Position | 166 | 2 | 32 | 813 | 3 |
| Net Cash Flow | $163 | $-29 | $-781 | $810 | $-73 |
| Free Cash Flow | |||||
| Operating Cash Flow | -302 | -991 | -1,719 | -1,654 | -272 |
| Free Cash Flow | -302 | -991 | -1,719 | -1,654 | -272 |